Depletion of glutathione by buthionine sulfoximine enhanced the embryotoxicity and teratogenicity of acrolein in the in vitro studies of Slott & Hales (1987a), whereas exogenous glutathione afforded protection against these effects (Slott & Hales, 1987b)
Dalavi, Mater
However, excessive expression of IFN-I enhances the autoreactive T cell- and B cell-mediated responses, ultimately resulting in the occurrence of autoimmunity (16, 39)
Not in the traditional sense
Side Effects and Safety Reported Side Effects (Rare) Mild headache (transient, first dose) Slight injection site irritation Nausea (if dosed too high on empty stomach) Sleep quality changes (usually improvement) Safety Profile Non-hormonal doesn't suppress testosterone or disrupt hormonal systems No major contraindications known No overdose risk excess peptide is simply cleared Well-tolerated across diverse populations No organ toxicity safe for liver, kidney, heart Contraindications (Caution) Active cancer growth-promoting effects could theoretically benefit cancer (no direct evidence, but be cautious) Pregnancy insufficient human data Active infection at injection site standard sterile injection protocols apply Drug Interactions No known major interactions with common medications
Bosentan reduces pulmonary artery pressure in high altitude residents
